Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ELTX compared with ENTX: revenue, margins and what each company keeps, and the suppliers and customers both name
ELTX
Elicio Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
ENTX
Entera Bio Ltd.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ELTX
Elicio Therapeutics, Inc.
vs
ENTX
Entera Bio Ltd.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ELTX, solid
ENTX, dashed
Supply-chain overlap
Revenue flow
ELTX: latest quarter not drawable. ENTX: latest quarter is a loss; flow not drawable.
Method
›
ELTX
Elicio Therapeutics, Inc.
Change
1.69
▼
−3.18%
· post 1.69
Mkt cap
$44.2M
Revenue
—
ENTX
Entera Bio Ltd.
Change
3.21
▲
+2.88%
· post 3.21
Closed
Oct 30 '26
Mkt cap
$161.4M
Revenue
$42,000
Q1 FY25
vs
Compare
Closed
Oct 30 '26
ELTX
Elicio Therapeutics, Inc.
vs
ENTX
Entera Bio Ltd.
1.69
▼
−3.18%
post 1.69
Price
3.21
▲
+2.88%
post 3.21
$44.2M
Mkt cap
$161.4M
—
Revenue
$42,000
Q1 FY25
Change
Change
ELTX
1.69
▼
−3.18%
vs
ENTX
3.21
▲
+2.88%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ELTX
6
—
Dr. Roberto Chiarle
unlisted
supplier
—
Gastro-Intestinal ("GI") Research Foundation
unlisted
supplier
—
Massachusetts Institute of Technology ("MIT")
unlisted
supplier
—
Memorial Sloan Kettering Cancer Center
unlisted
supplier
2 more · ELTX chain
›
Shared
0
No shared counterparties.
Only ENTX
1
OPK
OPKO Health
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR